drugset / Trial / NCT03393026
A Study of Lurasidone HCl in Subjects With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The study evaluates the effectiveness and safety of Lurasidone in subjects with schizophrenia over a period of 6 weeks.
Timeline
- Start
- 2018-01-03
- Primary completion
- 2019-09-17
- Completion
- 2019-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
| Subject | Lurasidone | Small molecule | 160 mg | Oral |